New CEO as of January 1, 2010.

MPI is proud to announce that as of January 1, 2010, Jon Askaa has a been appointed CEO of the company.

Jon Askaa comes from a position as Director of Companion Diagnostics at Genentech Inc. and has been responsible for development and
implementation of Companion Diagnostic assays for Genentech's targeted therapy programs. Before that he worked at Dako in Denmark and in California and was responsible for the development and launch of the HercepTest companion diagnostic and several other Companion
Diagnostic assays.

With Jon Askaa'a experience in developing and launching companion diagnostic products, the service that MPI offers to biotech and pharmaceutical companies will be even better and broader than before.

Jan 5. 2010

Announcements